Quality by design approach for formulation development of extended release dosage form for an antimuscarinic agent
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: PALEM, Chinna Reddy (Hetero Labs Ltd.,, Formulation Research and Development, Hyderabad, India)
- Co-author(s): Pakala, Subrahmanyam (Hetero Labs Ltd.,, Hyderabad, India)
Background/Aim: The purpose of the present investigation was to develop an extended release dosage form for an antimuscarinic agent using quality by design (QbD) approach.
Methods: The quality target product profile of an antimuscarinic drug was identified and initial risk analysis led to the identification of the critical quality attributes... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.